Mariner LLC lessened its stake in KKR & Co. Inc. (NYSE:KKR - Free Report) by 4.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 531,391 shares of the asset manager's stock after selling 25,696 shares during the period. Mariner LLC owned about 0.06% of KKR & Co. Inc. worth $78,598,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in KKR. Vanguard Group Inc. increased its position in KKR & Co. Inc. by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 56,687,516 shares of the asset manager's stock valued at $8,384,650,000 after purchasing an additional 441,817 shares during the period. Geode Capital Management LLC raised its stake in KKR & Co. Inc. by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 14,047,900 shares of the asset manager's stock worth $2,073,624,000 after buying an additional 458,048 shares during the last quarter. FMR LLC boosted its position in KKR & Co. Inc. by 6.7% during the fourth quarter. FMR LLC now owns 12,003,389 shares of the asset manager's stock valued at $1,775,421,000 after acquiring an additional 752,056 shares during the last quarter. Norges Bank acquired a new stake in KKR & Co. Inc. during the 4th quarter worth about $1,435,314,000. Finally, Charles Schwab Investment Management Inc. raised its position in shares of KKR & Co. Inc. by 2.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,772,331 shares of the asset manager's stock worth $557,965,000 after acquiring an additional 85,461 shares in the last quarter. Institutional investors and hedge funds own 76.26% of the company's stock.
Analyst Ratings Changes
Several equities research analysts recently commented on KKR shares. Citigroup decreased their target price on KKR & Co. Inc. from $177.00 to $132.00 and set a "buy" rating for the company in a research note on Tuesday, April 8th. HSBC upgraded shares of KKR & Co. Inc. from a "hold" rating to a "buy" rating and lowered their price objective for the company from $170.00 to $119.00 in a research note on Tuesday, April 15th. Hsbc Global Res upgraded shares of KKR & Co. Inc. from a "hold" rating to a "strong-buy" rating in a report on Tuesday, April 15th. Barclays dropped their price objective on shares of KKR & Co. Inc. from $181.00 to $129.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. Finally, Bank of America decreased their target price on KKR & Co. Inc. from $214.00 to $194.00 and set a "buy" rating for the company in a research report on Friday, April 4th. One analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $144.93.
Get Our Latest Analysis on KKR
KKR & Co. Inc. Stock Up 1.2 %
Shares of KKR traded up $1.24 during trading hours on Friday, reaching $103.29. 3,725,114 shares of the stock traded hands, compared to its average volume of 4,954,040. KKR & Co. Inc. has a 52 week low of $86.15 and a 52 week high of $170.40. The company has a market cap of $91.75 billion, a price-to-earnings ratio of 31.02, a PEG ratio of 1.00 and a beta of 1.77. The stock has a fifty day simple moving average of $117.65 and a 200 day simple moving average of $138.59. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.82.
KKR & Co. Inc. Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were given a dividend of $0.175 per share. The ex-dividend date was Friday, February 14th. This represents a $0.70 annualized dividend and a dividend yield of 0.68%. KKR & Co. Inc.'s dividend payout ratio is currently 21.02%.
Insider Transactions at KKR & Co. Inc.
In related news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the completion of the sale, the insider now directly owns 19,260,971 shares of the company's stock, valued at approximately $634,841,604.16. This trade represents a 23.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 39.34% of the company's stock.
About KKR & Co. Inc.
(
Free Report)
KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm's business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.
Read More

Before you consider KKR & Co. Inc., you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KKR & Co. Inc. wasn't on the list.
While KKR & Co. Inc. currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.